Organ preservation solutions for whole organ pancreas transplantation

Current Opinion in Organ Transplantation

Volumn 16, Issue 1, 2011, Pages 116-122

  Fridell, Jonathan A ^a   Mangus, Richard S ^a   Powelson, John A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Celsior solution; histidinetryptophanketoglutarate solution; organ preservation; pancreas transplantation; University of Wisconsin solution

Indexed keywords

CELSIOR; HTK SOLUTION; UNIVERSITY OF WISCONSIN SOLUTION;

ARTICLE; COLD ISCHEMIA; HUMAN; ORGAN PRESERVATION; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PANCREATITIS;

HUMANS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PANCREAS; PANCREAS TRANSPLANTATION;

EID: 78751620785     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283424d06     Document Type: Article

References (52)

1. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19:433-455.
2. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001; 233:463-501.
3. Sollinger HW, Odorico JS, Becker YT, et al. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009; 250:618-630.
4. Humar A, Kandaswamy R, Granger D, et al. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231:269-275.
5. Stratta RJ, Lo A, Shokouh-Amiri MH, et al. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. Transpl Int 2003; 16:154-160.
6. Wahlberg JA, Southard JH, Belzer FO. Development of a cold storage solution for pancreas preservation. Cryobiology 1986; 23:477-482.
7. Ploeg RJ, Goossens D, Sollinger HW, et al. The Belzer-UW solution for effective long-term preservation in canine pancreas transplantation. Transplant Proc 1989 21:1378-1380.
8. Tullius SG, Filatenkow A, Horch D, et al. Accumulation of crystal deposits in abdominal organs following perfusion with defrosted University of Wisconsin solutions. Am J Transplant 2002; 2:627-630.
9. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28:295-302.
10. Blech M, Hummel G, Kallerhoff M, Ringert RH. Electrolyte equilibration of human kidneys during perfusion with HTK-solution according to Bretschneider. Urol Res 1997; 25:331-335.
11. Potdar S, Malek S, Eghtesad B, et al. Initial experience using histidinetryptophan- ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18:661-665.
12. Dunn TB, DelCoro C, Ferrer J, et al. Risk factors for clinically significant graft pancreatitis: is it the solution? Am J Transplant 2008; 8 (Suppl 2):557; abstract# 1424.
13. Alonso D, Dunn TB, Rigley T, et al. Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale. Am J Transplant 2008; 8:1942-1945.
14. Agarwal A, Murdock P, Pescovitz MD, et al. Follow-up experience using histidine-tryptophan ketoglutarate solution in clinical pancreas transplantation. Transplant Proc 2005; 37:3523-3526.
15. Agarwal A, Powelson JA, Goggins WC, et al. Organ preservation with histidine-tryptophan ketogluatarate solution in clinical pancreas transplantation: an update of the Indiana University experience. Transplant Proc 2008; 40:498-501.
16. Mangus RS, Fridell JA, Vianna RM, et al. Comparison of histidine-tryptophanketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008; 14:365-373.
17. Fridell JA, Agarwal A, Milgrom ML, et al. Comparison of histidine-tryptophanketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77:1304-1306.
18. Agarwal A, Goggins WC, Pescovitz MD, et al. Comparison of histidinetryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc 2005; 37:2016-2019.
19. Agarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006; 81:480-482.
20. Lynch RJ, Kubus J, Chenault RH, et al. Comparison of histidine- tryptophanketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008; 8:567-573.
21. Stewart ZA, Lonze BE, Warren DS, et al. Histidine-tryptophan- ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants. Am J Transplant 2009; 9:1048-1054.
22. Alonso D, Dunn T, Rigley T, et al. Reduced kidney (KTx) and pancreas (PTx) allograft survival in transplanted organs flushed with high volumes of histidinetryptophan ketoglutarate (HTK) solution. American Transplant Congress; Toronto; 2008.
23. Becker T, Ringe B, Nyibata M, et al. Pancreas transplantation with histidinetryptophan- ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: is there a difference? JOP 2007; 8:304-311.
24. Englesbe MJ, Moyer A, Kim DY, et al. Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: a multicenter study. Transplantation 2006; 82:136-139.
25. Schneeberger S, Biebl M, Steurer W, et al. A prospective randomized multicenter trial comparing histidine-tryptophan-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation. Transpl Int 2009; 22:217-224.
26. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan- ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009; 9:217-221.
27. Fridell JA, Mangus RS, Powelson JA. Histidine-tryptophan-ketoglutarate for pancreas allograft preservation: the Indiana University experience. Am J Transplant 2010; 10:1284-1289.
28. Feng L, Zhao N, Yao X, et al. Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl 2007; 13:1125-1136.
29. Mangus RS, Tector AJ, Agarwal A, et al. Comparison of histidine-tryptophanketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl 2006; 12:226-230.
30. Meine MH, Zanotelli ML, Neumann J, et al. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine- tryptophan- ketoglutarate solutions in liver transplantation. Transplant Proc 2006; 38:1872-1875.
31. Pokorny H, Rasoul-Rockenschaub S, Langer F, et al. Histidine- tryptophanketoglutarate solution for organ preservation in human liver transplantation: a prospective multicentre observation study. Transpl Int 2004; 17:256-260.
32. Rayya F, Harms J, Martin AP, et al. Comparison of histidine- tryptophanketoglutarate solution and University of Wisconsin solution in adult liver transplantation. Transplant Proc 2008; 40:891-894.
33. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan- ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009; 9:286-293.
34. Salehi P, Hansen MA, Avila JG, et al. Human islet isolation outcomes from pancreata preserved with histidine-tryptophan ketoglutarate versus University of Wisconsin solution. Transplantation 2006; 82:983-985. (Pubitemid 44564047)
35. Mangus RS, Tector AJ, Fridell JA, et al. Comparison of histidine-tryptophanketoglutarate solution and University of Wisconsin solution in intestinal and multivisceral transplantation. Transplantation 2008; 86:298-302.
36. Gubernatis G, Dietl KH, Kemnitz J, et al. Extended cold preservation time (20 h 20 min) of a human liver graft by using cardioplegic HTK solution. Transplant Proc 1991; 23:2408-2409.
37. Gubernatis G, Pichlmayr R, Lamesch P, et al. HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences. Langenbecks Arch Chir 1990; 375:66-70.
38. Vega JD, Ochsner JL, Jeevanandam V, et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 2001; 71:1442-1447.
39. DArmini AM, Grande AM, Rinaldi M, et al. Prospective randomized clinical study of Celsior vs University of Wisconsin in double lung transplant. J Heart Lung Transplant 2001; 20:183.
40. Nardo B, Catena F, Cavallari G, et al. Randomized clinical study comparing UW and Celsior solution in liver preservation for transplantation: preliminary results. Transplant Proc 2001; 33 (1-2):870-872.
41. Meneu Diaz JC, Vicente E, Nuno J, et al. Prospective comparative study of the efficacy of Celsior solution for preservation in clinical liver transplant. Transplant Proc 2002; 34:49.
42. Cavallari A, Cillo U, Nardo B, et al. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003; 9:814-821.
43. Nardo B, Bertelli R, Montalti R, et al. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. Transplant Proc 2005; 37:320-322.
44. Lopez-Andujar R, Deusa S, Montalva E, et al. Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior. Liver Transpl 2009; 15:1709-1717.
45. Faenza A, Catena F, Nardo B, et al. Kidney preservation with university of Wisconsin and Celsior solution: a prospective multicenter randomized study. Transplantation 2001; 72:1274-1277.
46. Marcen R, Burgos FJ, Ocana J, et al. Wisconsin and Celsior solutions in renal preservation: a comparative preliminary study. Transplant Proc 2005; 37:1419-1420.
47. Nunes P, Mota A, Figueiredo A, et al. Efficacy of renal preservation: comparative study of Celsior and University of Wisconsin solutions. Transplant Proc 2007; 39:2478-2479.
48. Boggi U, Vistoli F, Del Chiaro M, et al. Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study. Transplantation 2004; 77:1186-1190.
49. Boggi U, Coletti L, Vistoli F, et al. Pancreas preservation with University of Wisconsin and Celsior solutions. Transplant Proc 2004; 36:563-565.
50. Boggi U, Signori S, Vistoli F, et al. University of Wisconsin solution versus Celsior solution in clinical pancreas transplantation. Transplant Proc 2005; 37:1262-1264.
51. Manrique A, Jimenez C, Herrero ML, et al. Pancreas preservation with the University of Wisconsin versus Celsior solutions. Transplant Proc 2006; 38:2582-2584.
52. Nicoluzzi J, Macri M, Fukushima J, Pereira A. Celsior versus Wisconsin solution in pancreas transplantation. Transplant Proc 2008; 40:3305-3307.